Athira Pharma Inc. (ATHA)
NASDAQ: ATHA
· Real-Time Price · USD
0.33
-0.03 (-8.33%)
At close: Jun 09, 2025, 3:59 PM
Athira Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -9.14M | -15M | -28.74M | -26.86M | -26.34M | -27.29M | -32.97M | -29.6M | -27.82M | -30.14M | -20.19M | -24.34M | -20.98M | -16.34M | -15.67M | -13.97M | -8.87M |
Depreciation & Amortization | 178K | 243K | -245K | 242K | 242K | 245K | 244K | 244K | 236K | 239K | 231K | 221K | 154K | 126K | 123K | 118K | 112K |
Stock-Based Compensation | 1.64M | 2.23M | 2.94M | 3.21M | 2.68M | 2.23M | 2.49M | 3.12M | 2.78M | 2.36M | 2.42M | 3.1M | 2.73M | 1.44M | 1.1M | 1.11M | 974K |
Other Working Capital | n/a | -15.15M | 160K | -105K | 1.07M | 166K | -361K | 803K | 1.29M | 10.07M | -2.83M | -62K | 1.17M | -8.7M | 4.03M | 5.33M | 718K |
Other Non-Cash Items | n/a | 36K | 2.03M | 2.29M | 6.21M | 3.91M | 54K | 53K | -280K | -306K | -154K | 47K | 185K | 146K | 121K | 95K | 131K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -4.14M | -394K | -406K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -13.52M | 998K | 1.19M | -2.19M | -1.25M | 6.59M | 2.31M | -1.11M | 12.18M | -3.95M | 2.37M | 1.34M | -3.54M | 4.03M | 5.33M | 344K |
Operating Cash Flow | -14.66M | -26.01M | -23.02M | -22.33M | -25.8M | -26.29M | -23.98M | -24.28M | -26.19M | -15.67M | -21.64M | -18.59M | -16.57M | -18.18M | -10.3M | -7.32M | -7.3M |
Capital Expenditures | n/a | n/a | n/a | -28K | -5K | n/a | -30K | -33K | -241K | -1K | -244K | -151K | -745K | -1.03M | -128K | -114K | -304K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | 89K | -20.72K | -32.52K | -35.76K | -24.65K | -13.88K | n/a | n/a | -18.05M | n/a | n/a | n/a |
Purchase of Investments | -10.2M | -2.81M | n/a | -5.41M | -5.91M | n/a | -2.78M | -15.18M | -9.71M | -10.17M | -33.45M | -33.84M | -17.83M | -29.82M | -95.81M | -80.42M | -93.14M |
Sales Maturities Of Investments | 2.85M | n/a | 18.04M | 32M | 18.96M | 6.39M | 23.5M | 47.7M | 45.48M | 34.82M | 47.32M | 29.53M | 42.42M | 52.22M | 81.74M | 91.99M | 70.74M |
Other Investing Acitivies | n/a | n/a | n/a | 26.59M | 13.05M | 6.39K | 20.72K | 32.52K | 35.76K | 24.65K | 13.88K | -4.31M | 24.59M | 18.05M | -14.07M | 11.57M | -22.4M |
Investing Cash Flow | -7.35M | -2.81M | 18.04M | 26.56M | 13.04M | 6.39M | 20.69M | 32.49M | 35.52M | 24.65M | 13.63M | -4.46M | 23.85M | 21.37M | -14.2M | 11.46M | -22.71M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -260K | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 34K | 12K | 148K | n/a | 152K | n/a | 242K | 99K | 147K | n/a | 297K | 210K | 13K | 125K | 150K | 39K |
Financial Cash Flow | n/a | 34K | 12K | 148K | n/a | 152K | n/a | 242K | 99K | 147K | n/a | 297K | 210K | 13K | 125K | -260K | 97.21M |
Net Cash Flow | -22.02M | -28.79M | -4.97M | 4.38M | -12.76M | -19.75M | -3.29M | 8.45M | 9.43M | 9.13M | -8.01M | -22.75M | 7.48M | 3.21M | -24.37M | 3.88M | 67.2M |
Free Cash Flow | -14.66M | -26.01M | -23.02M | -22.36M | -25.81M | -26.29M | -24.01M | -24.32M | -26.43M | -15.67M | -21.88M | -18.74M | -17.32M | -19.2M | -10.43M | -7.43M | -7.61M |